These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9017481)

  • 21. Use of intramuscular ketamine by paramedics in the management of severely agitated patients.
    Bernard S; Roggenkamp R; Delorenzo A; Stephenson M; Smith K;
    Emerg Med Australas; 2021 Oct; 33(5):875-882. PubMed ID: 33763938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Droperidol use in the emergency department is not safe.
    Prosser RL
    Acad Emerg Med; 2006 May; 13(5):585-6; author reply 586-7. PubMed ID: 16641482
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department.
    Martel ML; Driver BE; Miner JR; Biros MH; Cole JB
    Acad Emerg Med; 2021 Apr; 28(4):421-434. PubMed ID: 32888340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid tranquilization of the agitated patient in the emergency department: A systematic review and network meta-analysis.
    deSouza IS; Thode HC; Shrestha P; Allen R; Koos J; Singer AJ
    Am J Emerg Med; 2022 Jan; 51():363-373. PubMed ID: 34823192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between droperidol use and sudden death in two patients intoxicated with illicit stimulant drugs.
    Cox RD; Koelliker DE; Bradley KG
    Vet Hum Toxicol; 2004 Feb; 46(1):21-3. PubMed ID: 14748411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Droperidol: efficacy and side effects in psychiatric emergencies.
    Chambers RA; Druss BG
    J Clin Psychiatry; 1999 Oct; 60(10):664-7. PubMed ID: 10549682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Sud P; Nelson L; Diller D
    Ann Emerg Med; 2013 May; 61(5):597-8. PubMed ID: 23622027
    [No Abstract]   [Full Text] [Related]  

  • 28. Intubation of Profoundly Agitated Patients Treated with Prehospital Ketamine.
    Olives TD; Nystrom PC; Cole JB; Dodd KW; Ho JD
    Prehosp Disaster Med; 2016 Dec; 31(6):593-602. PubMed ID: 27640730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.
    Yap CYL; Taylor DM; Knott JC; Taylor SE; Phillips GA; Karro J; Chan EW; Kong DCM; Castle DJ
    Addiction; 2017 Jul; 112(7):1262-1269. PubMed ID: 28160494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone.
    Richards JR; Derlet RW; Duncan DR
    Eur J Emerg Med; 1997 Sep; 4(3):130-5. PubMed ID: 9426992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of ketamine versus haloperidol for severe prehospital agitation.
    Cole JB; Moore JC; Nystrom PC; Orozco BS; Stellpflug SJ; Kornas RL; Fryza BJ; Steinberg LW; O'Brien-Lambert A; Bache-Wiig P; Engebretsen KM; Ho JD
    Clin Toxicol (Phila); 2016 Aug; 54(7):556-62. PubMed ID: 27102743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the effectiveness and safety of droperidol for pediatric agitation in acute care settings.
    Ramsden SC; Pergjika A; Janssen AC; Mudahar S; Fawcett A; Walkup JT; Hoffmann JA
    Acad Emerg Med; 2022 Dec; 29(12):1466-1474. PubMed ID: 35490341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of droperidol in behavioural emergencies.
    Shale JH; Shale CM; Mastin WD
    Expert Opin Drug Saf; 2004 Jul; 3(4):369-78. PubMed ID: 15268653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral sedation of elderly patients with acute behavioral disturbance in the ED.
    Calver L; Isbister GK
    Am J Emerg Med; 2013 Jun; 31(6):970-3. PubMed ID: 23685060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rapid tranquillisation for agitated patients with psychostimulant intoxication].
    Geerts P; Titeca K; Lemmens GMD; De Fruyt J
    Tijdschr Psychiatr; 2017; 59(6):360-365. PubMed ID: 28613368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Droperidol versus haloperidol for chemical restraint of agitated and combative patients.
    Thomas H; Schwartz E; Petrilli R
    Ann Emerg Med; 1992 Apr; 21(4):407-13. PubMed ID: 1554179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of severe emergence agitation using droperidol.
    Hatzakorzian R; Shan WL; Côté AV; Schricker T; Backman SB
    Anaesthesia; 2006 Nov; 61(11):1112-5. PubMed ID: 17042853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Droperidol use in pediatric emergency department patients.
    Szwak K; Sacchetti A
    Pediatr Emerg Care; 2010 Apr; 26(4):248-50. PubMed ID: 20401969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ziprasidone for sedation of the agitated ED patient.
    Martel ML
    Am J Emerg Med; 2004 May; 22(3):238. PubMed ID: 15138973
    [No Abstract]   [Full Text] [Related]  

  • 40. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.
    Martel ML; Klein LR; Rivard RL; Cole JB
    Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.